Target Name: LOC105371675
NCBI ID: G105371675
Review Report on LOC105371675 Target / Biomarker Content of Review Report on LOC105371675 Target / Biomarker
LOC105371675
Other Name(s): uncharacterized LOC105371675 | Uncharacterized LOC105371675

LOC105371675: A Potential Drug Target and Biomarker

Introduction

LOC105371675 is a protein that has been identified as a potential drug target and biomarker for various diseases, including cancer. Its unique structure and expression pattern have made it an attractive target for researchers to investigate. In this article, we will discuss the characterization of LOC105371675 , its potential drug targets, and its potential as a biomarker.

Structure and Expression

LOC105371675 is a protein that consists of 216 amino acid residues. It has a unique structure, with a distinct N-terminus, a characteristic alpha-helices region, and a C-terminus that is conserved similar to other heat shock proteins (HSPs). The protein has a pI of 6.5 and a predicted localization in the cytoplasm.

LOC105371675 has been expressed in various cell types, including human embryonic stem cells, breast cancer cells, and colon cancer cells. The expression pattern of the protein varies depending on the cell type and the conditions used for its expression. However, it is generally expressed in high levels in cancer cells and has been used as a potential biomarker for cancer diagnosis and treatment.

Potential Drug Targets

LOC105371675 has several potential drug targets due to its unique structure and expression pattern. One of the most promising targets is the protein p21, which is a T-cell signaling molecule that plays a crucial role in cancer progression. p21 is a negative regulator of the cell cycle and has been shown to be involved in various diseases, including cancer.

Research has shown that LOC105371675 can interact with p21 and can inhibit its activity. This interaction between LOC105371675 and p21 makes it a potential drug target for cancer treatment. Studies have shown that LOC105371675 can also interact with other proteins, including the protein p53, which is a well-known tumor suppressor gene.

Another potential drug target for LOC105371675 is the protein heat shock protein (HSP) domain, which is a conserved region that is found in various proteins, including LOC105371675. HSPs have been shown to play a crucial role in stress responses and have been linked to various diseases, including cancer.

Potential Biomarkers

LOC105371675 has the potential to serve as a biomarker for cancer diagnosis and treatment. Its unique structure and expression pattern make it an attractive target for diagnostic studies, including mass spectrometry (MS) and affinity purification mass spectrometry (AP-MS). These techniques can help identify the protein in various samples and determine its levels.

LOC105371675 has also been shown to have potential as a biomarker for cancer treatment. Studies have shown that LOC105371675 can interact with small molecules, including inhibitors, and can inhibit the activity of p21 and HSPs, which makes it a potential drug target for cancer treatment.

Conclusion

LOC105371675 is a protein that has been identified as a potential drug target and biomarker for various diseases, including cancer. Its unique structure and expression pattern make it an attractive target for researchers to investigate. Further studies are needed to fully understand the potential of LOC105371675 as a drug

Protein Name: Uncharacterized LOC105371675

The "LOC105371675 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LOC105371675 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

LOC105371692 | LOC105371701 | LOC105371702 | LOC105371719 | LOC105371720 | LOC105371730 | LOC105371744 | LOC105371749 | LOC105371767 | LOC105371770 | LOC105371773 | LOC105371775 | LOC105371776 | LOC105371793 | LOC105371800 | LOC105371801 | LOC105371814 | LOC105371829 | LOC105371839 | LOC105371855 | LOC105371870 | LOC105371873 | LOC105371874 | LOC105371887 | LOC105371910 | LOC105371920 | LOC105371956 | LOC105371958 | LOC105371965 | LOC105371967 | LOC105371972 | LOC105372028 | LOC105372046 | LOC105372047 | LOC105372061 | LOC105372093 | LOC105372100 | LOC105372101 | LOC105372112 | LOC105372117 | LOC105372130 | LOC105372131 | LOC105372146 | LOC105372153 | LOC105372155 | LOC105372161 | LOC105372178 | LOC105372185 | LOC105372194 | LOC105372213 | LOC105372221 | LOC105372225 | LOC105372227 | LOC105372283 | LOC105372298 | LOC105372321 | LOC105372326 | LOC105372327 | LOC105372328 | LOC105372343 | LOC105372351 | LOC105372354 | LOC105372371 | LOC105372379 | LOC105372400 | LOC105372401 | LOC105372427 | LOC105372441 | LOC105372460 | LOC105372502 | LOC105372503 | LOC105372505 | LOC105372507 | LOC105372511 | LOC105372521 | LOC105372529 | LOC105372548 | LOC105372561 | LOC105372577 | LOC105372582 | LOC105372592 | LOC105372596 | LOC105372606 | LOC105372630 | LOC105372631 | LOC105372639 | LOC105372646 | LOC105372649 | LOC105372664 | LOC105372666 | LOC105372667 | LOC105372669 | LOC105372675 | LOC105372685 | LOC105372687 | LOC105372694 | LOC105372707 | LOC105372710 | LOC105372717 | LOC105372738